Microbot Medical Inc is primarily active in the medical technology industry. As a cutting-edge company, Microbot Medical specializes in the development and commercialization of robotic technologies focused on improved medical procedures and treatments. With its innovative product portfolio, Microbot Medical aims to revolutionize various medical fields such as urology, neurology, and cardiovascular healthcare. Through its dedication to technological advancements and industry collaborations, Microbot Medical strives to provide healthcare professionals and patients with breakthrough solutions that enhance overall medical outcomes.

The main competitors of Microbot Medical Inc in the market include companies such as Medtronic, Intuitive Surgical, and Johnson & Johnson.

Microbot Medical Inc is a leading medical device company specializing in the development of transformational micro-robotic technologies. Established in 2010, Microbot Medical Inc aims to improve patient outcomes through the development of innovative robotic platforms designed for minimally invasive surgeries and targeted therapies. The company's cutting-edge technologies utilize advanced engineering and robotics to address significant unmet medical needs in various medical fields, including urology, gastroenterology, and ENT (ear, nose, and throat). With its commitment to revolutionizing medical interventions, Microbot Medical Inc continues to push boundaries in the field of robotic medicine, creating new possibilities for improved patient care.

Microbot Medical Inc has achieved several significant milestones. Firstly, the company successfully developed and received regulatory clearance for its innovative robotic technologies in the medical industry. Additionally, Microbot Medical Inc has made notable advancements in the fields of urology, neurology, and gastrointestinal procedures. The company has also successfully completed important clinical studies and collaborations with leading medical institutions. Moreover, Microbot Medical Inc has secured intellectual property rights for its proprietary technologies, which strengthens its position in the market. These milestones demonstrate the company's dedication to improving healthcare outcomes and solidify its reputation as a leader in the medical robotics field.

Microbot Medical Inc is primarily present in the United States, Israel, and Europe. This company, specializing in micro-robotics technologies, operates in multiple regions to distribute their innovative medical devices and solutions. Microbot Medical Inc's presence in these countries and regions enables them to reach a significant market and collaborate with leading medical institutions, professionals, and industry experts. By establishing a global footprint, Microbot Medical Inc aims to enhance patient outcomes and revolutionize the field of medical robotics.

Microbot Medical Inc represents values of innovation, advancement, and patient-centric healthcare solutions. With a strong corporate philosophy aimed at addressing unmet medical needs, Microbot Medical Inc is dedicated to developing and commercializing transformative robotic technologies. By combining novel engineering with medical expertise, the company aims to improve patient outcomes, reduce healthcare costs, and enhance overall quality of life. Microbot Medical Inc strives to empower physicians and healthcare professionals with cutting-edge tools and solutions, all while prioritizing patient safety and well-being.

Analysts currently set an average price target of 6,80 USD for the Microbot Medical stock (median: 5,10 USD), implying +350,3 % versus the latest price. The consensus is based on 8 analyst ratings.

Microbot Medical Analist Fiyat Hedefleri 2026

9 analysts currently rate the Microbot Medical stock: 8 recommend buying, 1 holding and 0 selling. For 2026, analysts expect Microbot Medical to generate revenue of 2,83 M USD and earnings per share of -0,07 USD.

Microbot Medical Analist Fiyat Hedefleri 2026

Converted at the current exchange rate, the Microbot Medical share trades at 1,29 EUR (1,50 USD).

The Microbot Medical share (MBOT) is listed on 4 stock exchanges, including: NASDAQ (MBOT), Frankfurt (CY9D.F), München (CY9D.MU), Düsseldorf (CY9D.DU).

Microbot Medical Inc is a leading company in the development and commercialization of miniature robots for medical applications. The company is based in Israel and also has branches in the USA.

beklenen'nin Microbot Medical hasılatı 2,83 M USD'dir. Bu rakam, mevcut finansal verilere dayanmakta ve şirketin iş performansını yansıtmaktadır.

beklenen'nin Microbot Medical karı -4,38 M USD'dir. Net kar, tüm giderleri düştükten sonra şirketin kârlılığını gösterir.

Microbot Medical'nin Fiyat/Kazanç (F/K) oranı şu anda -23,00'dir. F/K oranı, cari hisse fiyatını hisse başına kazançla karşılaştırır ve yatırımcıların Microbot Medical hisse senedinin değerlemesini değerlendirmelerine yardımcı olur.

Microbot Medical'nin Fiyat/Satış (F/S) oranı şu anda 35,66'dir. F/S oranı, pazar kapitalizasyonunu yıllık gelirle karşılaştırır ve Microbot Medical hisse senedinin değerleme metriği olarak hizmet eder.

Microbot Medical'nin Eulerpool Kalite Puanı 2/10'dur.

Microbot Medical'nin ISIN'i US59503A2042'dir. ISIN (Uluslararası Menkul Kıymetler Kimlik Numarası), menkul kıymetler için küresel olarak benzersiz bir tanımlayıcıdır.

Microbot Medical'nin WKN'i A2N5AS'dir. WKN (Wertpapierkennnummer), menkul kıymetleri tanımlamak için kullanılan altı haneli bir Alman kimlik numarasıdır.

Microbot Medical'nin ticker'ı MBOT'dir. Ticker sembolü, Microbot Medical hisseleri borsada işlem görmek için kullanılır.

Microbot Medical son 0 yıl boyunca her yıl temettü ödemiştir.

Microbot Medical, 'Sağlık' sektörüne atanmıştır.

Microbot Medical'un temettüleri USD cinsinden dağıtılır.